Literature DB >> 17210474

The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases.

Marta Ruiz-Ortega1, Vanesa Esteban, Jesús Egido.   

Abstract

The renin angiotensin system (RAS) participates in the pathogenesis of cardiovascular diseases. Although angiotensin II has been considered the effector peptide of RAS, accumulating evidence shows that other RAS peptides also posses important functions, some of them involved in cardiovascular pathology. Many studies support the importance of N-terminal angiotensin degradation product, angiotensin IV (AngIV), in the fields of cognition, renal metabolism, and pathophysiologic conditions. The novel data discussed here show that AngIV could contribute to cardiovascular damage. Angiotensin IV can be generated by degradation of angiotensin II, by aminopeptidase (AP) N, or by other proteases, which could be activated during tissue damage, suggesting that elevated AngIV levels can be found in pathologic conditions. Angiotensin IV binds to a specific receptor, AT(4), which has recently been identified as an insulin-regulated AP. In vascular cells, correspondence between AT(4) binding sites and insulin-regulated AP has been described. Angiotensin IV regulates cell growth in cardiac fibroblasts, endothelial cells, and vascular smooth muscle cells (VSMCs). In VSMC, AngIV, through AT(4), independently of AT(1) and AT(2) receptors, activates the nuclear factor-kappaB pathway and up-regulates several nuclear factor-kappaB-related genes, including the monocyte chemokine monocyte chemoattractant protein-1, the adhesion molecule intercellular adhesion molecule-1, and the cytokines interleukin 6 and tumor necrosis factor alpha. These data indicate that AngIV could be involved in the vascular inflammatory response. Thus, in endothelial cells and VSMC, AngIV up-regulates plasminogen activator inhibitor-1 expression and could participate in thrombus formation. These results reveal novel concepts of RAS in the cardiovascular system, suggesting that AngIV could play an active role in vascular diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210474     DOI: 10.1016/j.tcm.2006.10.003

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  23 in total

1.  Angiotensin IV is induced in experimental autoimmune encephalomyelitis but fails to influence the disease.

Authors:  Arndt Manzel; Oliver Domenig; Bjoern Ambrosius; Agnes Kovacs; Johannes Stegbauer; Marko Poglitsch; Dominik N Mueller; Ralf Gold; Ralf A Linker
Journal:  J Neuroimmune Pharmacol       Date:  2014-05-23       Impact factor: 4.147

Review 2.  Role of central and peripheral aminopeptidase activities in the control of blood pressure: a working hypothesis.

Authors:  Manuel Ramírez; Isabel Prieto; Francisco Alba; Francisco Vives; Inmaculada Banegas; Marc de Gasparo
Journal:  Heart Fail Rev       Date:  2008-03-29       Impact factor: 4.214

3.  Molecular and Cellular Effect of Angiotensin 1-7 on Hypertensive Kidney Disease.

Authors:  Yuanjian Chen; Wenyuan Zhao; Chang Liu; Weixin Meng; Tieqiang Zhao; Syamal K Bhattacharya; Yao Sun
Journal:  Am J Hypertens       Date:  2019-04-22       Impact factor: 2.689

4.  The X-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing.

Authors:  Alan H M Wong; Dongxia Zhou; James M Rini
Journal:  J Biol Chem       Date:  2012-08-29       Impact factor: 5.157

5.  Angiotensin IV upregulates the activity of protein phosphatase 1α in Neura-2A cells.

Authors:  Dan Wang; Peng Xue; Xiu Lan Chen; Zhen Sheng Xie; Fu Quan Yang; Li Zheng; Tao Xu
Journal:  Protein Cell       Date:  2013-06-06       Impact factor: 14.870

Review 6.  Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review.

Authors:  Bart Stragier; Dimitri De Bundel; Sophie Sarre; Ilse Smolders; Georges Vauquelin; Alain Dupont; Yvette Michotte; Patrick Vanderheyden
Journal:  Heart Fail Rev       Date:  2007-11-08       Impact factor: 4.214

Review 7.  Biochemical and enzymatic properties of the M1 family of aminopeptidases involved in the regulation of blood pressure.

Authors:  Masafumi Tsujimoto; Yoshikuni Goto; Masato Maruyama; Akira Hattori
Journal:  Heart Fail Rev       Date:  2007-11-13       Impact factor: 4.214

8.  Prospective evaluation of aminopeptidase activities in plasma and peripheral organs of streptozotocin-induced diabetic rats.

Authors:  L Zambotti-Villela; S C Yamasaki; J S Villarroel; R F Alponti; P F Silveira
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

9.  Angiotensin II relaxations of bovine adrenal cortical arteries: role of angiotensin II metabolites and endothelial nitric oxide.

Authors:  Kathryn M Gauthier; David X Zhang; Lijie Cui; Kasem Nithipatikom; William B Campbell
Journal:  Hypertension       Date:  2008-05-19       Impact factor: 10.190

Review 10.  Age-related changes in redox signaling and VSMC function.

Authors:  Muyao Li; Naomi K Fukagawa
Journal:  Antioxid Redox Signal       Date:  2010-03-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.